Cargando…
External validation of predictive scores for diabetes remission after metabolic surgery
PURPOSE: Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic sur...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847237/ https://www.ncbi.nlm.nih.gov/pubmed/34255166 http://dx.doi.org/10.1007/s00423-021-02260-3 |
_version_ | 1784652009609101312 |
---|---|
author | Karpińska, Izabela A. Choma, Joanna Wysocki, Michał Dudek, Alicja Małczak, Piotr Szopa, Magdalena Pędziwiatr, Michał Major, Piotr |
author_facet | Karpińska, Izabela A. Choma, Joanna Wysocki, Michał Dudek, Alicja Małczak, Piotr Szopa, Magdalena Pędziwiatr, Michał Major, Piotr |
author_sort | Karpińska, Izabela A. |
collection | PubMed |
description | PURPOSE: Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic surgery have been established to facilitate the decision-making process. The purpose of the study is to validate the performance of available risk prediction scores for diabetes remission a year after surgical treatment and to determine the optimal model. METHODS: A retrospective analysis comprised 252 patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2009 and 2017 and completed 1-year follow-up. The literature review revealed 5 models, which were subsequently explored in our study. Each score relationship with diabetes remission was assessed using logistic regression. Discrimination was evaluated by area under the receiver operating characteristic (AUROC) curve, whereas calibration by the Hosmer–Lemeshow test and predicted versus observed remission ratio. RESULTS: One year after surgery, 68.7% partial and 21.8% complete diabetes remission and 53.4% excessive weight loss were observed. DiaBetter demonstrated the best predictive performance (AUROC 0.81; 95% confidence interval (CI) 0.71–0.90; p-value > 0.05 in the Hosmer–Lemeshow test; predicted-to-observed ratio 1.09). The majority of models showed acceptable discrimination power. In calibration, only the DiaBetter score did not lose goodness-of-fit in all analyzed groups. CONCLUSION: The DiaBetter score seems to be the most appropriate tool to predict diabetes remission after metabolic surgery since it presents adequate accuracy and is convenient to use in clinical practice. There are no accurate models to predict T2DM remission in a patient with advanced diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-021-02260-3. |
format | Online Article Text |
id | pubmed-8847237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88472372022-02-23 External validation of predictive scores for diabetes remission after metabolic surgery Karpińska, Izabela A. Choma, Joanna Wysocki, Michał Dudek, Alicja Małczak, Piotr Szopa, Magdalena Pędziwiatr, Michał Major, Piotr Langenbecks Arch Surg Original Article PURPOSE: Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic surgery have been established to facilitate the decision-making process. The purpose of the study is to validate the performance of available risk prediction scores for diabetes remission a year after surgical treatment and to determine the optimal model. METHODS: A retrospective analysis comprised 252 patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2009 and 2017 and completed 1-year follow-up. The literature review revealed 5 models, which were subsequently explored in our study. Each score relationship with diabetes remission was assessed using logistic regression. Discrimination was evaluated by area under the receiver operating characteristic (AUROC) curve, whereas calibration by the Hosmer–Lemeshow test and predicted versus observed remission ratio. RESULTS: One year after surgery, 68.7% partial and 21.8% complete diabetes remission and 53.4% excessive weight loss were observed. DiaBetter demonstrated the best predictive performance (AUROC 0.81; 95% confidence interval (CI) 0.71–0.90; p-value > 0.05 in the Hosmer–Lemeshow test; predicted-to-observed ratio 1.09). The majority of models showed acceptable discrimination power. In calibration, only the DiaBetter score did not lose goodness-of-fit in all analyzed groups. CONCLUSION: The DiaBetter score seems to be the most appropriate tool to predict diabetes remission after metabolic surgery since it presents adequate accuracy and is convenient to use in clinical practice. There are no accurate models to predict T2DM remission in a patient with advanced diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-021-02260-3. Springer Berlin Heidelberg 2021-07-13 2022 /pmc/articles/PMC8847237/ /pubmed/34255166 http://dx.doi.org/10.1007/s00423-021-02260-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Karpińska, Izabela A. Choma, Joanna Wysocki, Michał Dudek, Alicja Małczak, Piotr Szopa, Magdalena Pędziwiatr, Michał Major, Piotr External validation of predictive scores for diabetes remission after metabolic surgery |
title | External validation of predictive scores for diabetes remission after metabolic surgery |
title_full | External validation of predictive scores for diabetes remission after metabolic surgery |
title_fullStr | External validation of predictive scores for diabetes remission after metabolic surgery |
title_full_unstemmed | External validation of predictive scores for diabetes remission after metabolic surgery |
title_short | External validation of predictive scores for diabetes remission after metabolic surgery |
title_sort | external validation of predictive scores for diabetes remission after metabolic surgery |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847237/ https://www.ncbi.nlm.nih.gov/pubmed/34255166 http://dx.doi.org/10.1007/s00423-021-02260-3 |
work_keys_str_mv | AT karpinskaizabelaa externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT chomajoanna externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT wysockimichał externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT dudekalicja externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT małczakpiotr externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT szopamagdalena externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT pedziwiatrmichał externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery AT majorpiotr externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery |